Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.

T Robak; M Błasinka-Morawiec; E Krykowski; M Kasznicki; A Płuzanska; P Potemski; A Hellmann; J M Zaucha; K Lewandowski; A Dmoszynska

doi:10.3109/10428199609054790

Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.

Identifier:nobleid.org/w1/20260515/B3D703CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B3D703CD.svg?ark=w1%2F20260515%2FB3D703CD)](https://nobleid.org/work/w1/20260515/B3D703CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.

Identifier:nobleid.org/w1/20260515/B3D703CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B3D703CD.svg?ark=w1%2F20260515%2FB3D703CD)](https://nobleid.org/work/w1/20260515/B3D703CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work